Sentinel Lymph Node Biopsy in Breast Cancer: Current Status and Recent Progress
- 13 Downloads
Sentinel lymph node biopsy (SLNB) is a standard procedure used to evaluate the status of axillary lymph nodes (ALNs) that are clinically tumor-free in patients with early-stage breast cancer. Recent research on SLNB has led to continual improvements in the scope of application, accuracy in information provided, and relevance of the results for subsequent treatment. This review is based on selective searches of the Springer Publishing Company and PubMed databases for articles about progress and developments of SLNB in patients with breast cancer. The main purposes are to summarize the current status and established indications for SLNB, identify specific topics that are still under debate, and suggest specific areas where further studies are most needed.
KeywordsSentinel lymph node biopsy Axillary lymph node dissection Breast cancer Neoadjuvant chemotherapy Isolated tumor cells Micrometastases
We are grateful to our colleagues and their families for supporting the work.
All authors have read and approved the submission of the manuscript.
Compliance with Ethical Standards
Conflict of interest
The manuscript has not been published and is not being considered for publication elsewhere, in whole or in part, in any language, except as an abstract. The authors declare that they have no competing interests.
- 2.Gherghe M, Bordea C, Blidaru A (2014) Sentinel lymph node biopsy (SLNB) vs. axillary lymph node dissection (ALND) in the current surgical treatment of early stage breast cancer.[J]. J Med Life 8(2):176–180Google Scholar
- 12.Krag DN, Anderson SJ, Julian TB et al (2007) Technical outcomes of sentinel-lymph-node resection and conventional axillary-lymph-node dissection in patients with clinically node-negative breast cancer: results from the NSABP B-32 randomised phase III trial : The Lancet Oncology [J]. Lancet Oncol 8(10):881–888CrossRefGoogle Scholar
- 13.Lyman GH, Temin S, Edge SB, Newman LA, Turner RR, Weaver DL, Benson AB 3rd, Bosserman LD, Burstein HJ, Cody H 3rd, Hayman J, Perkins CL, Podoloff DA, Giuliano AE (2014) American Society of Clinical Oncology Clinical Practice. Sentinel lymph node biopsy for patients with early-stage breast cancer: American Society of Clinical Oncology clinical practice guideline update.[J]. J Clin Oncol 32(13):1365–1383CrossRefGoogle Scholar
- 14.Taguchi Y, Yasojima H, Masuda H et al (2014) 171. The long-term prognosis of sentinel lymph node-positive breast cancer patients without axillary dissection [J]. Clin Orthop Relat Res 40(11):1–31Google Scholar
- 20.Maimaitiaili A, Wu D, Liu Z, Liu H, Muyiduli X, Fan Z. Analysis of factors related to non-sentinel lymph node metastasis in 296 sentinel lymph node-positive Chinese breast cancer patients [published correction appears in Cancer Biol Med. 2018 Nov;15(4):478].Cancer Biol Med. 2018;15(3):282–289. doi:10.20892/j.issn.2095–3941.2018.0023Google Scholar
- 22.Melissa Pilewskie, Maria Karsten, Julia Radosa, et al. Is Sentinel Lymph Node Biopsy Indicated at Completion Mastectomy for Ductal Carcinoma In Situ?[J]. Annals of Surgical Oncology, 2016:1-6.Google Scholar
- 26.Han S N , Amant F , Sangalli C , et al. 266pd_prsentinel lymph node biopsy for breast cancer treatment during pregnancy - on behalf of the international network of cancer, infertility and pregnancy (incip) and the german breast group (gbg)[j]. Annals of Oncology, 2014, 25(4 (Supplement)).Google Scholar
- 30.Gallant E, Ewing C, Wong J, et al. Abstract P3-01-10: Sentinel lymph node biopsy after neoadjuvant chemotherapy for patients with clinically node-positive breast cancer: A single institution retrospective evaluation[J]. 2016, 76(4 Supplement):P3-01-10-P3-01-10.Google Scholar
- 32.Caudle AS, Yang W, Mittendorf EA, et al. Targeted axillary dissection improves axillary evaluation following neoadjuvant chemotherapy in node positive patients [C]// Cancer Symposium of the Society-Of-Surgical-Oncology. 2015:S6–S6.Google Scholar
- 33.Ahmed M , Douek M . Targeted axillary dissection after neoadjuvant therapy in breast cancer[J]. British Journal of Surgery, 2017.Google Scholar
- 34.Tomasz N, Andrzej K, Wojciech P et al (2016) Imaging methods for the local lymphatic system of the axilla in early breast cancer in patients qualified for sentinel lymph node biopsy:[J]. Menopausal Rev 15(1):52–55Google Scholar
- 36.Hung WK, Chan CM, Ying M et al (2006) Randomized clinical trial comparing blue dye with combined dye and isotope for sentinel lymph node biopsy in breast cancer [J]. J Electron Microsc 92(12):1494–1497Google Scholar
- 38.Sugie T, Kinoshita T, Masuda N et al (2015) Evaluation of the clinical utility of the ICG fluorescence method compared with the radioisotope method for sentinel lymph node biopsy in breast cancer [J]. Ann Surg Oncol 23(1):635–649Google Scholar
- 40.Deai T, Matumoto H, et al. Practice of fluorescence navigation surgery using indocyanine green for sentinel lymph node biopsy in breast cancer [M]// ICG Fluorescence Imaging and Navigation Surgery. Springer Japan, 2016.Google Scholar